biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by dexter08on Jun 04, 2013 1:35am

189 Views

Post# 21479629

RE: RE: RE: RE: $1.30 seems to be it for n

Well stock now lower than year with anon which is usually big money unloading everday since Shire deal fell thru basically says it all...Blah blah science hasn't changed but obviously those with the big cheque books see something else and were stuck with no buyers no deals this will slowly drift down....charts say it all no interest from market no interest from all these "big pharmas" obviously something not right guess we wait and see what it is.....no stock with all this "potential" and new studies trades lower than previous year if something not right..

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading